EFFICACY EVALUATION OF THE TRANSITION TO FIXED COMBINATION DRUG PRESTANCE IN PATIENTS WITH INSUFFICIENT CONTROL OF BLOOD PRESSURE BY OTHER ANTIHYPERTENSIVE MEDICATIONS OR COMBINATIONS: REGIONAL PROGRAM OBJECTIVE

Aim. To evaluate efficacy of the fixed combination of perindopril arginine and amlodipine (original drug PRESTANCE, JSC “Servier”, France) in achievement of blood pressure (BP) control in patients non­controlled with other antihypertensive medications.Material and methods. In the study, in real worl...

Full description

Saved in:
Bibliographic Details
Main Authors: A. Ya. Kravchenko, Z. Z. Alimkhanova
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2018-04-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/801
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849250074266173440
author A. Ya. Kravchenko
Z. Z. Alimkhanova
author_facet A. Ya. Kravchenko
Z. Z. Alimkhanova
author_sort A. Ya. Kravchenko
collection DOAJ
description Aim. To evaluate efficacy of the fixed combination of perindopril arginine and amlodipine (original drug PRESTANCE, JSC “Servier”, France) in achievement of blood pressure (BP) control in patients non­controlled with other antihypertensive medications.Material and methods. In the study, in real world setting, 250 arterial hypertension (AH) outpatients were included. The levels of systolic (SBP) and diastolic (DBP) blood pressure were assessed and “vascular age”, at baseline, in 1 and 3 months (visit 2) of treatment with PRESTANCE.Results. In transition of patients to PRESTANCE there was decrease of SBP from 166,6±8,9 to 142,1±6,1 mmHg in 1 month (р<0,001) and to 131,1±6,1 mmHg in 3 months. (р<0,001), that is by 36 mmHg. BP decrease with the studied drug was similar in men and women, in patients older and younger 60. Target BP was reached in 79,6% of patients. The parameter “vascular age” after transition to PRESTANCE decreased in 3 months from 67,3±10,5 y. o. to 59,2±8,86 y. o., that is by 8,1 years.Conclusion. Transition from mono­ or combination therapy to fixed combination of perindopril arginine/amlodipine releases rapid and potent antihypertensive efficacy in patients not reached the target BP at any previous therapy, including combination of perindopril with amlodipine.
format Article
id doaj-art-3077474a52ae4a8ea82061db1fc4ccc7
institution Kabale University
issn 1728-8800
2619-0125
language Russian
publishDate 2018-04-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj-art-3077474a52ae4a8ea82061db1fc4ccc72025-08-20T03:57:22Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252018-04-01172101610.15829/1728-8800-2018-2-10-16550EFFICACY EVALUATION OF THE TRANSITION TO FIXED COMBINATION DRUG PRESTANCE IN PATIENTS WITH INSUFFICIENT CONTROL OF BLOOD PRESSURE BY OTHER ANTIHYPERTENSIVE MEDICATIONS OR COMBINATIONS: REGIONAL PROGRAM OBJECTIVEA. Ya. Kravchenko0Z. Z. Alimkhanova1N.N. Burdenko Voronezhskiy State Medical University of the Ministry of HealthN.N. Burdenko Voronezhskiy State Medical University of the Ministry of HealthAim. To evaluate efficacy of the fixed combination of perindopril arginine and amlodipine (original drug PRESTANCE, JSC “Servier”, France) in achievement of blood pressure (BP) control in patients non­controlled with other antihypertensive medications.Material and methods. In the study, in real world setting, 250 arterial hypertension (AH) outpatients were included. The levels of systolic (SBP) and diastolic (DBP) blood pressure were assessed and “vascular age”, at baseline, in 1 and 3 months (visit 2) of treatment with PRESTANCE.Results. In transition of patients to PRESTANCE there was decrease of SBP from 166,6±8,9 to 142,1±6,1 mmHg in 1 month (р<0,001) and to 131,1±6,1 mmHg in 3 months. (р<0,001), that is by 36 mmHg. BP decrease with the studied drug was similar in men and women, in patients older and younger 60. Target BP was reached in 79,6% of patients. The parameter “vascular age” after transition to PRESTANCE decreased in 3 months from 67,3±10,5 y. o. to 59,2±8,86 y. o., that is by 8,1 years.Conclusion. Transition from mono­ or combination therapy to fixed combination of perindopril arginine/amlodipine releases rapid and potent antihypertensive efficacy in patients not reached the target BP at any previous therapy, including combination of perindopril with amlodipine.https://cardiovascular.elpub.ru/jour/article/view/801arterial hypertensionfixed combinationsprestancevascular age
spellingShingle A. Ya. Kravchenko
Z. Z. Alimkhanova
EFFICACY EVALUATION OF THE TRANSITION TO FIXED COMBINATION DRUG PRESTANCE IN PATIENTS WITH INSUFFICIENT CONTROL OF BLOOD PRESSURE BY OTHER ANTIHYPERTENSIVE MEDICATIONS OR COMBINATIONS: REGIONAL PROGRAM OBJECTIVE
Кардиоваскулярная терапия и профилактика
arterial hypertension
fixed combinations
prestance
vascular age
title EFFICACY EVALUATION OF THE TRANSITION TO FIXED COMBINATION DRUG PRESTANCE IN PATIENTS WITH INSUFFICIENT CONTROL OF BLOOD PRESSURE BY OTHER ANTIHYPERTENSIVE MEDICATIONS OR COMBINATIONS: REGIONAL PROGRAM OBJECTIVE
title_full EFFICACY EVALUATION OF THE TRANSITION TO FIXED COMBINATION DRUG PRESTANCE IN PATIENTS WITH INSUFFICIENT CONTROL OF BLOOD PRESSURE BY OTHER ANTIHYPERTENSIVE MEDICATIONS OR COMBINATIONS: REGIONAL PROGRAM OBJECTIVE
title_fullStr EFFICACY EVALUATION OF THE TRANSITION TO FIXED COMBINATION DRUG PRESTANCE IN PATIENTS WITH INSUFFICIENT CONTROL OF BLOOD PRESSURE BY OTHER ANTIHYPERTENSIVE MEDICATIONS OR COMBINATIONS: REGIONAL PROGRAM OBJECTIVE
title_full_unstemmed EFFICACY EVALUATION OF THE TRANSITION TO FIXED COMBINATION DRUG PRESTANCE IN PATIENTS WITH INSUFFICIENT CONTROL OF BLOOD PRESSURE BY OTHER ANTIHYPERTENSIVE MEDICATIONS OR COMBINATIONS: REGIONAL PROGRAM OBJECTIVE
title_short EFFICACY EVALUATION OF THE TRANSITION TO FIXED COMBINATION DRUG PRESTANCE IN PATIENTS WITH INSUFFICIENT CONTROL OF BLOOD PRESSURE BY OTHER ANTIHYPERTENSIVE MEDICATIONS OR COMBINATIONS: REGIONAL PROGRAM OBJECTIVE
title_sort efficacy evaluation of the transition to fixed combination drug prestance in patients with insufficient control of blood pressure by other antihypertensive medications or combinations regional program objective
topic arterial hypertension
fixed combinations
prestance
vascular age
url https://cardiovascular.elpub.ru/jour/article/view/801
work_keys_str_mv AT ayakravchenko efficacyevaluationofthetransitiontofixedcombinationdrugprestanceinpatientswithinsufficientcontrolofbloodpressurebyotherantihypertensivemedicationsorcombinationsregionalprogramobjective
AT zzalimkhanova efficacyevaluationofthetransitiontofixedcombinationdrugprestanceinpatientswithinsufficientcontrolofbloodpressurebyotherantihypertensivemedicationsorcombinationsregionalprogramobjective